this is where the market gets stupid. Celgene has a forward P/E of less than 15 and 20%+ growth. This is not some biotech start-up burning cash waiting on years of testing and FDA approval. This and other big biotechs are cash flow beasts with strong pipelines. I bought more today. Where's the risk? That said, I hope it goes lower... 90? 70?... as I have cash on the sidelines and will load up.